Literature DB >> 7559159

Release of angiotensin-converting enzyme (ACE) from human spermatozoa during capacitation and acrosome reaction.

F M Köhn1, W Miska, W B Schill.   

Abstract

The present study examines the release of angiotensin-converting enzyme (ACE) from human spermatozoa during capacitation conditions and in correlation to acrosome reaction and cell death. The ACE content of spermatozoa was measured by treating the cells with different detergents. Glass wool-filtered and washed human spermatozoa were incubated for 3 hours at 37 degrees C. Percentages of acrosome-reacted and dead spermatozoa did not change significantly, but the ACE release increased from 0 to 2.93 +/- 0.44 mU/100 x 10(6) spermatozoa after 180 minutes (P < 0.001). In order to study the influence of acrosome reaction on ACE release, the acrosome reaction of noncapacitated spermatozoa was induced by 10 microM calcium ionophore A23187. The percentages of acrosome reaction and viability in noncapacitated spermatozoa as well as the ACE release were compared to corresponding data from experiments using capacitated spermatozoa (3 hours, 37 degrees C) from the same donors. Although the number of living acrosome-reacted spermatozoa after ionophore treatment (30.5 +/- 4.0%) was significantly higher than after capacitation (13.3 +/- 2.8%, P < 0.001), ACE release from ionophore-treated, noncapacitated spermatozoa was lower (P < 0.05). The data indicate that ACE release from human spermatozoa during capacitation is independent of acrosome reaction. Measurement of ACE release may be a clinically useful assay for human sperm capacitation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559159

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  9 in total

1.  Angiotensin-converting enzyme and male fertility.

Authors:  J R Hagaman; J S Moyer; E S Bachman; M Sibony; P L Magyar; J E Welch; O Smithies; J H Krege; D A O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 2.  Angiotensin-converting enzymes play a dominant role in fertility.

Authors:  Pei-Pei Pan; Qi-Tao Zhan; Fang Le; Ying-Ming Zheng; Fan Jin
Journal:  Int J Mol Sci       Date:  2013-10-21       Impact factor: 5.923

3.  Human sperm testicular angiotensin-converting enzyme helps determine human embryo quality.

Authors:  Marta Gianzo; Itziar Urizar-Arenaza; Iraia Muñoa-Hoyos; Zaloa Larreategui; Nicolás Garrido; Luis Casis; Jon Irazusta; Nerea Subirán
Journal:  Asian J Androl       Date:  2018 Sep-Oct       Impact factor: 3.285

4.  Distribution of a novel binding site for angiotensins II and III in mouse tissues.

Authors:  Felicia M Rabey; Vardan T Karamyan; Robert C Speth
Journal:  Regul Pept       Date:  2010-02-19

5.  Reduced semen quality in patients with testicular cancer seminoma is associated with alterations in the expression of sperm proteins.

Authors:  Tânia R Dias; Ashok Agarwal; Peter N Pushparaj; Gulfam Ahmad; Rakesh Sharma
Journal:  Asian J Androl       Date:  2020 Jan-Feb       Impact factor: 3.285

6.  Concise practice recommendations for the provision of andrological services and assisted reproductive technology for male infertility patients during the SARS-CoV-2 in Brazil.

Authors:  Jorge Hallak; Sandro C Esteves
Journal:  Int Braz J Urol       Date:  2020 Nov-Dec       Impact factor: 1.541

Review 7.  Ligands and Receptors Involved in the Sperm-Zona Pellucida Interactions in Mammals.

Authors:  Lucie Tumova; Michal Zigo; Peter Sutovsky; Marketa Sedmikova; Pavla Postlerova
Journal:  Cells       Date:  2021-01-12       Impact factor: 6.600

Review 8.  Regulation of Male Fertility by the Renin-Angiotensin System.

Authors:  Marta Gianzo; Nerea Subirán
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

9.  Localization and Distribution of Testicular Angiotensin I Converting Enzyme (ACE) in Neck and Mid-Piece of Spermatozoa from Infertile Men in Relation to Sperm Motility.

Authors:  Mina Pencheva; Donka Keskinova; Pavel Rashev; Yvetta Koeva; Nina Atanassova
Journal:  Cells       Date:  2021-12-17       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.